On Invalid Date, Novartis Ag (NYSE: NVS) reported Q4 2023 earnings per share (EPS) of $4.14, up 500% year over year. Total Novartis Ag earnings for the quarter were $8.48 billion. In the same quarter last year, Novartis Ag's earnings per share (EPS) was $0.69.
As of Q2 2024, Novartis Ag's earnings has grown 124.14% year over year. This is 124.4 percentage points higher than the US Drug Manufacturers - General industry earnings growth rate of -0.26%. Novartis Ag's earnings in the past year totalled $14.85 billion.
What was NVS's revenue last quarter?
On Invalid Date, Novartis Ag (NYSE: NVS) reported Q4 2023 revenue of $11.78 billion up 7.39% year over year. In the same quarter last year, Novartis Ag's revenue was $10.97 billion.
What was NVS's revenue growth in the past year?
As of Q2 2024, Novartis Ag's revenue has grown 7.36% year over year. This is 2.84 percentage points higher than the US Drug Manufacturers - General industry revenue growth rate of 4.52%. Novartis Ag's revenue in the past year totalled $46.66 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.